NCT01569295

Trial results of0:01:49

Trial results of idelalisib with bendamustine and rituximab in CLL

Discussion of a0:02:47

Discussion of a Phase III trial evaluating the efficacy and safety of idelalisib

Trial of ibrutinib0:03:35

Trial of ibrutinib with bendamustine and rituximab in CLL: results and study design

Updated analysis of0:02:52

Updated analysis of Phase III trial of idelalisib combined with bendamustine and rituximab in CLL